207 related articles for article (PubMed ID: 23821282)
1. Evaluation of antiviral efficacy against human respiratory syncytial virus using cotton rat and mouse models.
Van den Berg J; Kwanten L; Roymans D
Methods Mol Biol; 2013; 1030():365-72. PubMed ID: 23821282
[TBL] [Abstract][Full Text] [Related]
2. In vivo evaluation of antiviral compounds on respiratory syncytial virus using a juvenile vervet monkey (Chlorocebus pygerythrus) infection model.
Houspie L; Stevens H; Ngotho M; Keyaerts E; Ispas G; Verloes R; Van Ranst M; Maes P
Methods Mol Biol; 2013; 1030():373-82. PubMed ID: 23821283
[TBL] [Abstract][Full Text] [Related]
3. Liu-He-Tang inhibited plaque formation by human respiratory syncytial virus infection in cell lines of the human respiratory tract.
Chang JS; Wang KC; Shieh DE; Chiang LC
J Ethnopharmacol; 2011 Oct; 137(3):1149-55. PubMed ID: 21810459
[TBL] [Abstract][Full Text] [Related]
4. Xiao-Qing-Long-Tang (Sho-seiryu-to) inhibited cytopathic effect of human respiratory syncytial virus in cell lines of human respiratory tract.
Chang JS; Yeh CF; Wang KC; Shieh DE; Yen MH; Chiang LC
J Ethnopharmacol; 2013 May; 147(2):481-7. PubMed ID: 23542148
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of respiratory syncytial virus in vitro and in vivo by the immunosuppressive agent leflunomide.
Dunn MC; Knight DA; Waldman WJ
Antivir Ther; 2011; 16(3):309-17. PubMed ID: 21555813
[TBL] [Abstract][Full Text] [Related]
6. Mouse and Cotton Rat Models of Human Respiratory Syncytial Virus.
Rudd PA; Chen W; Mahalingam S
Methods Mol Biol; 2016; 1442():209-17. PubMed ID: 27464697
[TBL] [Abstract][Full Text] [Related]
7. Ge-Gen-Tang has anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines.
Chang JS; Wang KC; Shieh DE; Hsu FF; Chiang LC
J Ethnopharmacol; 2012 Jan; 139(1):305-10. PubMed ID: 22120014
[TBL] [Abstract][Full Text] [Related]
8. Jiawei-Yupingfeng-Tang, a Chinese herbal formula, inhibits respiratory viral infections in vitro and in vivo.
Liu Q; Lu L; Hua M; Xu Y; Xiong H; Hou W; Yang Z
J Ethnopharmacol; 2013 Nov; 150(2):521-8. PubMed ID: 24051026
[TBL] [Abstract][Full Text] [Related]
9.
Rijsbergen LC; Rennick LJ; Laksono BM; van Run PRWA; Kuiken T; Duprex WP; de Swart RL; de Vries RD
J Gen Virol; 2020 Oct; 101(10):1037-1046. PubMed ID: 32692644
[TBL] [Abstract][Full Text] [Related]
10. Respiratory syncytial virus infection in macaques is not suppressed by intranasal sprays of pyrimidine biosynthesis inhibitors.
Grandin C; Hourani ML; Janin YL; Dauzonne D; Munier-Lehmann H; Paturet A; Taborik F; Vabret A; Contamin H; Tangy F; Vidalain PO
Antiviral Res; 2016 Jan; 125():58-62. PubMed ID: 26593978
[TBL] [Abstract][Full Text] [Related]
11. Water extract of Cinnamomum cassia Blume inhibited human respiratory syncytial virus by preventing viral attachment, internalization, and syncytium formation.
Yeh CF; Chang JS; Wang KC; Shieh DE; Chiang LC
J Ethnopharmacol; 2013 May; 147(2):321-6. PubMed ID: 23518419
[TBL] [Abstract][Full Text] [Related]
12. Cimicifuga foetida L. inhibited human respiratory syncytial virus in HEp-2 and A549 cell lines.
Wang KC; Chang JS; Chiang LC; Lin CC
Am J Chin Med; 2012; 40(1):151-62. PubMed ID: 22298455
[TBL] [Abstract][Full Text] [Related]
13. Anti-viral activity of water extract of Paeonia lactiflora pallas against human respiratory syncytial virus in human respiratory tract cell lines.
Lin TJ; Wang KC; Lin CC; Chiang LC; Chang JS
Am J Chin Med; 2013; 41(3):585-99. PubMed ID: 23711143
[TBL] [Abstract][Full Text] [Related]
14. Treatment of human respiratory syncytial virus infected Balb/C mice with the proteasome inhibitor bortezomib (Velcade, PS-341) results in increased inflammation and mortality.
Lupfer C; Patton KM; Pastey MK
Toxicology; 2010 Jan; 268(1-2):25-30. PubMed ID: 19931343
[TBL] [Abstract][Full Text] [Related]
15. Respiratory Syncytial Virus: pathology, therapeutic drugs and prophylaxis.
Gomez RS; Guisle-Marsollier I; Bohmwald K; Bueno SM; Kalergis AM
Immunol Lett; 2014 Nov; 162(1 Pt A):237-47. PubMed ID: 25268876
[TBL] [Abstract][Full Text] [Related]
16. Chloroquine and pyrimethamine inhibit the replication of human respiratory syncytial virus A.
Rahman F; Libre C; Oleinikov A; Tcherniuk S
J Gen Virol; 2021 Aug; 102(8):. PubMed ID: 34342560
[TBL] [Abstract][Full Text] [Related]
17. Benzimidazole analogs inhibit respiratory syncytial virus G protein function.
Evans CW; Atkins C; Pathak A; Gilbert BE; Noah JW
Antiviral Res; 2015 Sep; 121():31-8. PubMed ID: 26116756
[TBL] [Abstract][Full Text] [Related]
18. Antiviral effects of modified dingchuan decoction against respiratory syncytial virus infection in vitro and in an immunosuppressive mouse model.
Li L; Yu CH; Ying HZ; Yu JM
J Ethnopharmacol; 2013 May; 147(1):238-44. PubMed ID: 23506991
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by NMSO3 in tissue culture assays.
Wyde PR; Moylett EH; Chetty SN; Jewell A; Bowlin TL; Piedra PA
Antiviral Res; 2004 Jul; 63(1):51-9. PubMed ID: 15196820
[TBL] [Abstract][Full Text] [Related]
20. Prospects for the development of fusion inhibitors to treat human respiratory syncytial virus infection.
Bonfanti JF; Roymans D
Curr Opin Drug Discov Devel; 2009 Jul; 12(4):479-87. PubMed ID: 19562644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
